Catarina Matoso Abreu

Dr. Catarina Matoso Abreu

3Bs Research Group - University of Minho
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
CACatarina Matoso Abreu
Catarina Matoso Abreu
BCBruno Costa-Silva
Bruno Costa-Silva
RRRui M. Reis
Rui M. Reis
Subhas C. KunduSubhas C. Kundu
Subhas C. Kundu
David CaballeroDavid Caballero
David Caballero
Microfluidic devices as powerful tools for point-of-care testing and design of EV-based cancer therapeutics.

1 January 2022 in Biomaterials
Verified
Journal Article
Closed access
David CaballeroDavid Caballero
David Caballero
CACatarina Matoso Abreu
Catarina Matoso Abreu
ALAna C. Lima
Ana C. Lima
NNNuno M. Neves
Nuno M. Neves
RRRui L. Reis
Rui L. Reis
Subhas C. KunduSubhas C. Kundu
Subhas C. Kundu

17 January 2021 in Biosensors
Verified
Journal Article
Open access
PDF file
Agnes PurwidyantriAgnes Purwidyantri
Agnes Purwidyantri
TDTelma Domingues
Telma Domingues
JBJérôme Borme
Jérôme Borme
JGJoana Rafaela Guerreiro
Joana Rafaela Guerreiro
AIAndrey Ipatov
Andrey Ipatov
Marta PradoMarta Prado
Marta Prado
Liquid-gated Graphene Field-Effect Transistors (GFET) are ultrasensitive bio-detection platforms carrying out the graphene’s exceptional intrinsic functionalities. Buffer and dilution factor are prevalent strategies towards the optimum performance of the GFETs. However, beyond the Debye length (λD), the role of the graphene-electrolytes’ ionic species interactions on the DNA behavior at the nanoscale interface is complicated. We studied the characteristics of the GFETs under different ionic strength, pH, and electrolyte type, e.g., phosphate buffer (PB), and phosphate buffer saline (PBS), in an automatic portable built-in system. The electrostatic gating and charge transfer phenomena were inferred from the field-effect measurements of the Dirac point position in single-layer graphene (SLG) transistors transfer curves. Results denote that λD is not the main factor governing the effective nanoscale screening environment. We observed that the longer λD was not the determining characteristic for sensitivity increment and limit of detection (LoD) as demonstrated by different types and ionic strengths of measuring buffers. In the DNA hybridization study, our findings show the role of the additional salts present in PBS, as compared to PB, in increasing graphene electron mobility, electrostatic shielding, intermolecular forces and DNA adsorption kinetics leading to an improved sensitivity.

16 May 2018 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
PDF file
CACatarina Matoso Abreu
Catarina Matoso Abreu
RSRicardo Soares-Dos-Reis
Ricardo Soares-Dos-Reis
PMPedro N. Melo
Pedro N. Melo
JRJoao Relvas
Joao Relvas
JGJoana Guimarães
Joana Guimarães
IMInês Pinto Mendes-Pinto
Inês Pinto Mendes-Pinto
Neuroinflammation plays a critical role in the onset and progression of many neurological disorders, including Multiple Sclerosis, Alzheimer's and Parkinson's diseases. In these clinical conditions the underlying neuroinflammatory processes are significantly heterogeneous. Nevertheless, a common link is the chronic activation of innate immune responses and imbalanced secretion of pro and anti-inflammatory mediators. In light of this, the discovery of robust biomarkers is crucial for screening, early diagnosis, and monitoring of neurological diseases. However, the difficulty to investigate biochemical processes directly in the central nervous system (CNS) is challenging. In recent years, biomarkers of CNS inflammatory responses have been identified in different body fluids, such as blood, cerebrospinal fluid, and tears. In addition, progress in micro and nanotechnology has enabled the development of biosensing platforms capable of detecting in real-time, multiple biomarkers in clinically relevant samples. Biosensing technologies are approaching maturity where they will become deployed in community settings, at which point screening programs and personalized medicine will become a reality. In this multidisciplinary review, our goal is to highlight both clinical and recent technological advances toward the development of multiplex-based solutions for effective neuroinflammatory and neurodegenerative disease diagnostics and monitoring.

10 May 2021 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
Joaquim OliveiraJoaquim Oliveira
Joaquim Oliveira
MCM. R. Carvalho
M. R. Carvalho
DFD. C. Fernandes
D. C. Fernandes
CACatarina Matoso Abreu
Catarina Matoso Abreu
F.Raquel MaiaF.Raquel Maia
F.Raquel Maia
Joaquim OliveiraJoaquim Oliveira
Joaquim Oliveira
A human 3D inflammatory cartilage-on-a chip model was develop as a drug screening platform to evaluate the therapeutic efficacy of anti-TNFα mAb-CS/PAMAM dendrimer NPs loaded-Tyramine-Gellan Gum Hydrogel.

15 April 2019 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
ACAndrea Cruz
Andrea Cruz
RQRaquel Queirós
Raquel Queirós
CACatarina Matoso Abreu
Catarina Matoso Abreu
CBCatarina Barata
Catarina Barata
Rosa FernandesRosa Fernandes
Rosa Fernandes
IMInês Pinto Mendes-Pinto
Inês Pinto Mendes-Pinto